WENDY DEMKO: Open Payments
NPI 1780926378 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 88 payments from 23 companies in 2025. Trend: 2023 $1,436 · 2024 $1,851 · 2025 $1,675
Food & beverage: $1,675
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $285 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| Amgen Inc. | 9 | $153 |
| Lilly USA, LLC | 6 | $124 |
| GlaxoSmithKline, LLC. | 6 | $121 |
| SANOFI-AVENTIS U.S. LLC | 3 | $93 |
| Eisai Inc. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| PFIZER INC. | 4 | $64 |
Products named: Ozempic, BREZTRI, TZIELD, Leqembi, OTEZLA, Kerendia, LEQVIO, EVENITY.
Industry payments across FL — which companies pay providers there.
